A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance

Hybrid therapy is a novel two-step treatment achieving a high eradication rate for Helicobacter pylori infection. Currently, whether this new therapy achieves a higher eradication rate than bismuth quadruple therapy remains an unanswered question. The aim of this prospective, randomized comparative...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Antimicrob Agents Chemother
Autors principals: Tsay, Feng-Woei, Wu, Deng-Chyang, Yu, Hsien-Chung, Kao, Sung-Shuo, Lin, Kung-Hung, Cheng, Jin-Shiung, Wang, Huay-Min, Chen, Wen-Chi, Sun, Wei-Chih, Tsai, Kuo-Wang, Hsu, Ping-I
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2017
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5655074/
https://ncbi.nlm.nih.gov/pubmed/28807915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00140-17
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars